editor
novel
coronaviru
caus
probabl
case
sever
acut
respiratori
syndrom
sar
worldwid
outbreak
etiolog
agent
identifi
diagnosi
sar
made
accord
set
clinicalepidemiolog
criteria
suggest
center
diseas
control
prevent
cdc
criteria
remain
import
initi
diagnosi
prompt
isol
patient
overal
sensit
initi
revers
transcriptasepolymeras
chain
reaction
test
sarsassoci
coronaviru
sarscov
rna
upper
respiratori
specimen
rang
approxim
though
sensit
improv
second
test
sar
screen
clinic
princ
wale
emerg
depart
posit
predict
valu
ppv
criteria
estim
ci
rel
import
clinic
versu
epidemiolog
criteria
evalu
use
pair
serolog
test
determin
sarscov
infect
evalu
rel
import
clinicalepidemiolog
diagnost
criteria
outbreak
patient
diagnosi
sar
admit
one
five
region
hospit
hong
kong
isol
treatment
march
june
includ
retrospect
analysi
probabl
sar
casepati
met
cdc
clinic
criteria
sever
respiratori
ill
unknown
etiolog
met
epidemiolog
criterion
exposur
either
close
possibl
contact
close
contact
defin
care
live
direct
contact
bodi
fluid
probabl
sar
patient
eg
work
medic
ward
stay
household
within
day
initi
symptom
hong
kong
document
sar
transmiss
site
februari
juli
modifi
epidemiolog
criterion
possibl
contact
adopt
possibl
contact
defin
stay
work
hospit
compound
resid
build
case
cluster
sar
report
within
day
symptom
onset
laboratori
test
pair
immunoglobulin
ig
g
antibodi
sarscov
use
determin
infect
posit
serolog
evid
infect
defin
fourfold
rise
antibodi
titer
detect
antibodi
convalescentphas
serum
seroneg
defin
absenc
antibodi
convalescentphas
serum
obtain
day
symptom
onset
seroneg
defin
time
frame
day
serum
collect
juli
beyond
day
exclud
diagnosi
sar
sampl
patient
show
nonspecif
fluoresc
signal
consid
neg
sarscov
infect
rtpcr
perform
clinic
specimen
respiratori
fecal
patient
demograph
laboratori
paramet
histori
close
contact
compar
seroposit
seroneg
group
student
test
use
analyz
continu
variabl
p
valu
consid
statist
signific
odd
ratio
confid
interv
ci
calcul
categor
variabl
studi
period
patient
hospit
probabl
sar
one
hundr
patient
exclud
serolog
result
either
miss
n
die
day
ill
convalescentphas
serum
n
three
hundr
seventyf
patient
includ
analys
patient
serologyposit
sarscov
two
hundr
sixtythre
patient
increas
antibodi
titer
patient
detect
antibodi
either
acut
convalescentphas
serum
sampl
titer
twentytwo
patient
antibodi
titer
convalescentphas
serum
sampl
median
day
rang
day
clinic
specimen
posit
sarscov
rtpcr
thu
ppv
clinicalepidemiolog
criteria
sar
cohort
ci
contact
histori
demograph
laboratori
paramet
seroposit
seroneg
group
depict
tabl
proport
patient
histori
close
contact
significantli
higher
seroposit
group
seroneg
group
vs
ci
patient
serolog
confirm
result
close
contact
histori
seroneg
patient
categori
ppv
close
contact
ci
ppv
possibl
contact
ci
seroposit
patient
significantli
lower
lymphocyt
count
admiss
compar
seroneg
patient
vs
x
p
ppv
possibl
contact
plu
lymphopenia
x
x
ci
ci
respect
seroneg
patient
older
vs
year
less
like
healthcar
worker
vs
venu
contact
commun
vs
higher
total
leukocyt
count
admiss
vs
x
differ
found
lactat
dehydrogenas
activ
partial
thromboplastin
time
creatinin
phosphokinas
alanineaminotransferas
level
two
group
fifteen
seroneg
patient
respond
antibiot
five
die
comorbid
ill
one
carcinoma
lung
one
metastat
carcinoma
prostat
two
chronic
pulmonari
diseas
one
congest
heart
failur
two
die
bacteri
pneumonia
four
patient
bacteri
pathogen
identifi
one
methicillinresist
staphylococcu
aureu
two
stenotrophomona
maltophilia
one
pseudomona
aeruginosa
also
patient
coexist
medic
condit
three
congest
heart
failur
four
chronic
pulmonari
diseas
two
chronic
renal
failur
two
advanc
malign
two
diabet
mellitu
two
parkinson
diseas
find
show
case
defin
probabl
sar
basi
clinicalepidemiolog
criteria
serolog
evid
coronaviru
infect
set
criteria
associ
ppv
high
local
outbreak
ppv
cdc
epidemiolog
criterion
close
contact
higher
ppv
possibl
contact
appli
lymphopenia
ppv
becam
higher
analysi
illustr
histori
close
contact
patient
sarscov
infect
major
import
diagnos
infect
find
support
hypothesi
sarscov
transmit
respiratori
droplet
physic
contact
patient
bodi
fluid
although
specif
lymphopenia
subsequ
progress
highli
preval
among
sar
patient
clinician
advis
world
health
organ
hematolog
deviat
eg
lymphopenia
consid
sar
evalu
studi
limit
sampl
size
retrospect
statu
nonetheless
demonstr
accuraci
diagnost
criteria
outbreak
import
epidemiolog
criteria
studi
need
evalu
diagnost
accuraci
criteria
nonoutbreak
situat
case
preval
low
